BiotechTube
Home/Aktis Oncology/Shulamit Ron-Bigger, PhD
SR

Shulamit Ron-Bigger, PhD

Chief Operating Officer

Aktis Oncology

Therapeutic Areas

OncologySolid Tumors

Aktis Oncology Pipeline

DrugIndicationPhase
AKY-1189Nectin-4 expressing solid tumors (Urothelial Carcinoma, Breast Cancer, NSCLC, Colorectal Cancer, Cervical Cancer)Phase 1b
AKY-2519B7-H3 (CD276) expressing solid tumors (Prostate, Lung, and other solid tumors)IND-Enabling
Multiple ProgramsUndisclosed solid tumorsDiscovery

Leadership Team at Aktis Oncology

MR
Matthew Roden, PhD
President, Chief Executive Officer
TB
Tyler Benedum, PhD
Chief Technical Officer
AC
Akos Czibere, MD, PhD
Chief Medical Officer
PL
Paul L. Feldman, PhD
Chief Scientific Officer
KK
Kyle Kuvalanka
Chief Financial Officer
TF
Todd Foley
Co-founder and Chairman of the Board
KH
Ken Herrmann, MD
Independent Director, Chair of Scientific Advisory Board
View full Aktis Oncology profile